Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm.
Gregory A JoiceJames L LiuArthur L BurnettPublished in: BJU international (2021)
RIP remains a medically neglected condition with current management focused on treating the acute condition rather than modulating the course of disease. Continued research into the molecular mechanisms of RIP and standardized clinical pathways can improve the quality of care for patients suffering from this condition.
Keyphrases
- healthcare
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- prognostic factors
- palliative care
- liver failure
- small molecule
- signaling pathway
- patient reported outcomes
- intensive care unit
- drug induced
- respiratory failure
- chronic pain
- smoking cessation
- aortic dissection
- single molecule